about
Review of vancomycin-induced renal toxicity: an updateDecreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogramHow do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.Basis for selecting optimum antibiotic regimens for secondary peritonitis.A specially tailored vancomycin continuous infusion regimen for renally impaired critically ill patients.Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice.Continuous vancomycin in a pediatric cystic fibrosis patient.
P2860
Q26746932-4332220E-797D-4FE3-84CD-C17C479C050FQ34777837-33D2FA85-F2C5-4326-8627-E7C544F399EAQ34894900-9592681F-F8F1-4AE8-ABBC-5C7AA42846E3Q38417173-D23F242E-AAD9-4595-8E3A-230C51DB7040Q38633450-037A6658-534D-4986-A61F-41ED38D2D877Q40104555-2B980F5D-7A33-42D1-A782-1EEFE3A1482BQ48089081-92739F17-487D-4576-9DC0-44EC897D32B8Q48199296-E5782FEA-C4E3-447A-879A-90F9BA31DCE9
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Review of continuous-infusion vancomycin.
@en
type
label
Review of continuous-infusion vancomycin.
@en
prefLabel
Review of continuous-infusion vancomycin.
@en
P2860
P356
P1476
Review of continuous-infusion vancomycin.
@en
P2093
Kelly Rafferty
V Paul DiMondi
P2860
P304
P356
10.1345/APH.1R420
P407
P577
2013-02-05T00:00:00Z